Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeru Toyoda

Showing results (81-90 of 175) with videos related to

Pageof 18
Sort By:
Cureus|May 19, 2025
Prediction of Japan Score and Society of Thoracic Surgeons Risk Scores for Patients Undergoing Cardiovascular Surgery by Serum Growth Differentiation Factor-15 and Endothelin-1 LevelsTaira Fukuda, Takashi Kato, Yuta Kanazawa, et al.
Heart and Vessels|May 21, 2017
Comparison of echocardiographic parameters to assess right ventricular function in pulmonary hypertensionHirohisa Amano, Shichiro Abe, Suguru Hirose, et al.
JACC. Case Reports|September 2, 2021
Pacemaker Treatment for Apical Hypertrophic Cardiomyopathy in the Setting of an Apical Ventricular AneurysmShigeru Toyoda, Keitaro Ida, Yoshiyuki Kitagawa, et al.
Journal of Gastroenterology|September 1, 2004
The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer diseaseSeiichi Kato, Yoshikazu Nishino, Kyoko Ozawa, et al.
Helicobacter|October 23, 2002
Emergence of clarithromycin-resistant Helicobacter pylori (CRHP) with a high prevalence in children compared with their parentsIkue Taneike, Satoshi Goshi, Yukiko Tamura, et al.
International Journal of Cardiology|October 8, 2017
Myeloid-related protein-8/14 in acute coronary syndromeMasashi Sakuma, Atsushi Tanaka, Norihiko Kotooka, et al.
Cardiovascular Diabetology|June 29, 2021
Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trialAtsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Cardiovascular Diabetology|August 1, 2021
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metforminAtsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Cureus|December 12, 2024
Relationship Between Serum ω-3 Polyunsaturated Fatty Acid Concentration and Fatty Acid Fraction of Epicardial Adipose Tissue in Patients With Cardiovascular DiseaseTaira Fukuda, Toshiaki Nakajima, Takaaki Hasegawa, et al.
International Journal of Cardiology. Heart & Vasculature|November 2, 2020
Association of serum growth differentiation factor-15 with eGFR and hemoglobin in healthy older femalesHiroko Yazawa, Taira Fukuda, Hiroyuki Kaneda, et al.
Pageof 18

Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
Cureus|May 19, 2025
Prediction of Japan Score and Society of Thoracic Surgeons Risk Scores for Patients Undergoing Cardiovascular Surgery by Serum Growth Differentiation Factor-15 and Endothelin-1 LevelsTaira Fukuda, Takashi Kato, Yuta Kanazawa, et al.
Heart and Vessels|May 21, 2017
Comparison of echocardiographic parameters to assess right ventricular function in pulmonary hypertensionHirohisa Amano, Shichiro Abe, Suguru Hirose, et al.
JACC. Case Reports|September 2, 2021
Pacemaker Treatment for Apical Hypertrophic Cardiomyopathy in the Setting of an Apical Ventricular AneurysmShigeru Toyoda, Keitaro Ida, Yoshiyuki Kitagawa, et al.
Journal of Gastroenterology|September 1, 2004
The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer diseaseSeiichi Kato, Yoshikazu Nishino, Kyoko Ozawa, et al.
Helicobacter|October 23, 2002
Emergence of clarithromycin-resistant Helicobacter pylori (CRHP) with a high prevalence in children compared with their parentsIkue Taneike, Satoshi Goshi, Yukiko Tamura, et al.
International Journal of Cardiology|October 8, 2017
Myeloid-related protein-8/14 in acute coronary syndromeMasashi Sakuma, Atsushi Tanaka, Norihiko Kotooka, et al.
Cardiovascular Diabetology|June 29, 2021
Reduction of estimated fluid volumes following initiation of empagliflozin in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the placebo-controlled, randomized EMBLEM trialAtsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Cardiovascular Diabetology|August 1, 2021
Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metforminAtsushi Tanaka, Michio Shimabukuro, Hiroki Teragawa, et al.
Cureus|December 12, 2024
Relationship Between Serum ω-3 Polyunsaturated Fatty Acid Concentration and Fatty Acid Fraction of Epicardial Adipose Tissue in Patients With Cardiovascular DiseaseTaira Fukuda, Toshiaki Nakajima, Takaaki Hasegawa, et al.
International Journal of Cardiology. Heart & Vasculature|November 2, 2020
Association of serum growth differentiation factor-15 with eGFR and hemoglobin in healthy older femalesHiroko Yazawa, Taira Fukuda, Hiroyuki Kaneda, et al.
Pageof 18